A5081527302- Prenatal Screening and Diagnostics
- Ethics in Clinical Research
- Parvovirus B19 Infection Studies
- Genetics and Neurodevelopmental Disorders
- Genomics and Rare Diseases
- Child Nutrition and Feeding Issues
- Clinical Nutrition and Gastroenterology
- Genomic variations and chromosomal abnormalities
- Fetal and Pediatric Neurological Disorders
- Ethics and Legal Issues in Pediatric Healthcare
- Microtubule and mitosis dynamics
University Hospital of North Norway
2021-2022
Technological advances in both genome sequencing and prenatal imaging are increasing our ability to accurately recognize diagnose Mendelian conditions prenatally. Phenotype-driven early genetic diagnosis of fetal disease can help strategize treatment options clinical preventive measures during the perinatal period, plan utero therapies, inform parental decision-making. Fetal phenotypes diseases often unique at present not well understood; more comprehensive knowledge about computational...
Women's autonomy and an inclusive society for all individuals are highly valued in Norway. The Norwegian Biotechnology Act changed 2020 allowing first-trimester screening cell-free DNA common trisomies to pregnant women. However, implementing non-invasive prenatal testing (NIPT) a public antenatal care program is difficult, because many patients, politicians, medical professionals do not consider trisomy 21 severe disease. Screening at early gestation might inevitably lead increase pregnancy...